Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-28

Clinical Trial Update: Efficacy of Neorenal Forte for the Complete Elimination of Residual Fragments [NA]

View source ↗

Summary

Clinical trial update on the efficacy of Neorenal Forte for complete elimination of residual fragments in urolithiasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neorenal Forte

Snippet

Sponsor: Neopharm Bulgaria Ltd. | Conditions: Urolithiasis | NA | Status: RECRUITING